via Stanford University
Wearable devices can identify COVID-19 cases earlier than traditional diagnostic methods and can help track and improve management of the disease, Mount Sinai researchers report in one of the first studies on the topic.
The findings were published in the Journal of Medical Internet Research on January 29.
The Warrior Watch Study found that subtle changes in a participant’s heart rate variability (HRV) measured by an Apple Watch were able to signal the onset of COVID-19 up to seven days before the individual was diagnosed with the infection via nasal swab, and also to identify those who have symptoms.
“This study highlights the future of digital health,” says the study’s corresponding author Robert P. Hirten, MD, Assistant Professor of Medicine (Gastroenterology) at the Icahn School of Medicine at Mount Sinai, and member of the Hasso Plattner Institute for Digital Health at Mount Sinai and the Mount Sinai Clinical Intelligence Center (MSCIC). “It shows that we can use these technologies to better address evolving health needs, which will hopefully help us improve the management of disease. Our goal is to operationalize these platforms to improve the health of our patients and this study is a significant step in that direction. Developing a way to identify people who might be sick even before they know they are infected would be a breakthrough in the management of COVID-19.”
The researchers enrolled several hundred health care workers throughout the Mount Sinai Health System in an ongoing digital study between April and September 2020. The participants wore Apple Watches and answered daily questions through a customized app. Changes in their HRV—a measure of nervous system function detected by the wearable device—were used to identify and predict whether the workers were infected with COVID-19 or had symptoms. Other daily symptoms that were collected included fever or chills, tiredness or weakness, body aches, dry cough, sneezing, runny nose, diarrhea, sore throat, headache, shortness of breath, loss of smell or taste, and itchy eyes.
Additionally, the researchers found that 7 to 14 days after diagnosis with COVID-19, the HRV pattern began to normalize and was no longer statistically different from the patterns of those who were not infected.
“This technology allows us not only to track and predict health outcomes, but also to intervene in a timely and remote manner, which is essential during a pandemic that requires people to stay apart,” says the study’s co-author Zahi Fayad, PhD, Director of the BioMedical Engineering and Imaging Institute, Co-Founder of the MSCIC, and the Lucy G. Moses Professor of Medical Imaging and Bioengineering at the Icahn School of Medicine at Mount Sinai.
The Warrior Watch Study draws on the collaborative effort of the Hasso Plattner Institute for Digital Health and the MSCIC, which represents a diverse group of data scientists, engineers, clinical physicians, and researchers across the Mount Sinai Health System who joined together in the spring of 2020 to combat COVID-19. The study will next take a closer look at biometrics including HRV, sleep disruption, and physical activity to better understand which health care workers are at risk of the psychological effects of the pandemic.
More from: Icahn School of Medicine at Mount Sinai
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Detecting Covid-19 symptoms
- Data limitations are making it harder to detect when COVID-19 is surging in Virginia
Limited testing is making it harder to detect when COVID-19 is rising in Virginia. Current case rates are likely similar to last fall's surge.
- What Is BA.5? Everything We Know About Symptoms, Testing and Severity
Research so far shows that BA.5 doesn't overcome those protections against severe disease, though more research is needed to understand its clinical severity compared with earlier subvariants of ...
- What to Know About Omicron's BA.5: Symptoms, Testing and More
Here's what we know about BA.5. Right now there's no reason to suggest that the at-home rapid COVID-19 tests (a few boxes of which are free when you order through the government's website) are less ...
- Testing negative to COVID-19 but still have symptoms? Here's what you need to know
The Australian Medical Association has said there have been increasing reports of false negatives on rapid antigen tests. Could you be one of them?
- Proteomics profiling of COVID-19 patients identifies dysregulated proteins and pathways
Researchers assessed the impact of SARS-CoV-2 infection and severity on coronary and Alzheimer’s disease pathways.
Go deeper with Google Headlines on:
Detecting Covid-19 symptoms
Go deeper with Bing News on:
The future of digital health
- What Is The Future Of Health Care? Solution Collaboration
There is a need to better understand the solutions being offered and greatly improve the transformation process.
- The Future of Work and the Health-Care Workforce — ICYMI
Norma Padron, CEO and founder of EmpiricaLab, talks about health-care workforce challenges, the importance of facilitating collaboration in a hybrid world and how tech will help health-care teams work ...
- Digital health companies must act on health equity. This is the time.
In a world where care delivery and patient-to-provider interactions are increasingly facilitated by digital tools, and the makers of those tools count hundreds—even thousands—of healthcare ...
- Moving Analytics' CEO talks future of virtual heart care
As digital tools to remotely monitor patients grow increasingly sophisticated, investors are seeing opportunities to better tackle a long underserved (but sizable) market in virtual cardiac care.
- 1 big thing: Moving Analytics' CEO on the future of heart care
In the push to decentralize health care, virtual cardiac care is the latest digital health frontier, Moving Analytics CEO Harsh Vathsangam tells Erin.